Prostate Cancer Foundation

Donate Now | Shop the PCF Store | FAQs | Contact Us

Navigation

Home > Prostate Cancer Research > The Story of Abiraterone (Zytiga)

Text Size Bigger · Smaller | Print | Bookmark and Share

Research Accomplishments

Funded Research

Funding Strategy

Progress Reports

PCF Recognition Awards

Young Investigator Awards

Creativity Awards

Challenge Awards

Open RFA's

Review Committee

RFA Notification List Sign-Up

P²rovocative Questions

PCCTC

Scientific Retreat

Journal Club

Research News

Prostate Cancer Research

The Story of Abiraterone (Zytiga)

 

Related Stories:

Final European Approval of Abiraterone (Zytiga) Expected Within Weeks

FDA Aproves Zytiga (abiraterone acetate) for Late-Stage Prostate Cancer

Print | Bookmark and Share

Donate >

Help PCF fund research to find better treatments and a cure.

Get Involved>

Discover other ways you can help make a difference.

Stay Informed

Sign up to receive our monthly newsletters.

 

Research Summaries

News from PCF's annual meeting of prostate cancer researchers.

Progress Reports

State of Science Report

Updates on PCF-funded research.

PCF Guides

Image

Report to the Nation on Prostate Cancer: A Guide for Men and Their Families

Image

Nutrition, Exercise and Prostate Cancer

More